CBI presents “Navigating the Functional Service Provider Outsourcing Maze.”
CBI's Webinar Series
Navigating the Functional Service Provider Outsourcing Maze
June 4, 2008 * 1:00-2:00 PM Eastern
The panel of industry experts will show where biopharmas are seeing the greatest value from FSP outsourcing as well as discuss its often overlooked pitfalls, provide proven guidelines for effectively implementing this model, and offer detailed case study examples.
Attendees will discover:
Kenneth A. Getz, MBA,
Senior Research Fellow,
Tufts CSDD
Jennifer R. Goodfellow,
Senior Director, Clinical Outsourcing, Sepracor Inc.
Deirdre BeVard, Senior Director, Clinical Services,
ClearTrial, LLC
Navigating the Functional Service Provider Outsourcing Maze
June 4, 2008 * 1:00-2:00 PM Eastern
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.